PRLD: Prelude Therapeutics Incorporated Stocks News on June 1, 2025

$Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies$

PRLD

GlobeNewswire

6 months ago

Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies

November 2024's Top Picks: Penny Stocks On US Exchanges

PRLD

Simply Wall St.

6 months ago

November 2024's Top Picks: Penny Stocks On US Exchanges

PRLD

Zacks

6 months ago

After Plunging -31.47% in 4 Weeks, Here's Why the Trend Might Reverse for Prelude Therapeutics (PRLD)

Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit

PRLD

GlobeNewswire

6 months ago

Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit

PRLD

Zacks

7 months ago

Down -39.13% in 4 Weeks, Here's Why You Should You Buy the Dip in Prelude Therapeutics (PRLD)

Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

PRLD

GlobeNewswire

7 months ago

Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Prelude Therapeutics price target lowered to $1 from $3 at Barclays

PRLD

TipRanks

7 months ago

Prelude Therapeutics price target lowered to $1 from $3 at Barclays

Prelude Therapeutics Presents New Data from SMARCA Degrader Portfolio at the 36th EORTC-NCI-AACR Symposium

PRLD

GlobeNewswire

7 months ago

Prelude Therapeutics Presents New Data from SMARCA Degrader Portfolio at the 36th EORTC-NCI-AACR Symposium

Prelude Therapeutics Announces Publication of Abstracts for Presentation at the 36th EORTC-NCI-AACR Symposium

PRLD

GlobeNewswire

8 months ago

Prelude Therapeutics Announces Publication of Abstracts for Presentation at the 36th EORTC-NCI-AACR Symposium

PRLD

MT Newswires

9 months ago

Prelude Therapeutics Says PRT3789 Shows 'Encouraging Signs' in Phase 1 Trial; Shares Fall

PRLD

GlobeNewswire

9 months ago

Prelude Therapeutics’ SMARCA2 Degrader PRT3789 Demonstrated Promising Initial Clinical Activity and Safety Profile in Phase 1 Trial

Prelude Therapeutics Announces Publication of Abstract for Presentation at the European Society of Medical Oncology (ESMO) Congress 2024

PRLD

GlobeNewswire

9 months ago

Prelude Therapeutics Announces Publication of Abstract for Presentation at the European Society of Medical Oncology (ESMO) Congress 2024

MSD discontinues two Phase III Keytruda trials

PRLD

Clinical Trials Arena

9 months ago

MSD discontinues two Phase III Keytruda trials

PRLD

MT Newswires

10 months ago

Prelude Therapeutics Shares Fall After Reporting Wider Than Expected Q2 Loss

Prelude Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

PRLD

GlobeNewswire

10 months ago

Prelude Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

PRLD

Simply Wall St.

10 months ago

We're Keeping An Eye On Prelude Therapeutics' (NASDAQ:PRLD) Cash Burn Rate

Prelude and MSD partner to trial PRT3789 and Keytruda combination

PRLD

Clinical Trials Arena

a year ago

Prelude and MSD partner to trial PRT3789 and Keytruda combination

PRLD

MT Newswires

a year ago

Prelude Therapeutics Inks Deal With Merck for Phase 2 Study to Evaluate its SMARCA2 Degrader With Keytruda

Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination with KEYTRUDA® (pembrolizumab) in Patients with SMARCA4-Mutated Cancers

PRLD

GlobeNewswire

a year ago

Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination with KEYTRUDA® (pembrolizumab) in Patients with SMARCA4-Mutated Cancers

Spirit Aero downgraded, Skyworks upgraded: Wall Street's top analyst calls

PRLD

The Fly

a year ago

Spirit Aero downgraded, Skyworks upgraded: Wall Street's top analyst calls

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

PRLD

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

PRLD

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

PRLD

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

PRLD

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

PRLD

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

PRLD

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PRLD

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

PRLD

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences

PRLD

GlobeNewswire

a year ago

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences

PRLD

MT Newswires

a year ago

Prelude Therapeutics Files for $400 Million Mixed Shelf

Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference

PRLD

GlobeNewswire

a year ago

Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference

Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

PRLD

GlobeNewswire

a year ago

Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Several Insiders Invested In Prelude Therapeutics Flagging Positive News

PRLD

Simply Wall St.

a year ago

Several Insiders Invested In Prelude Therapeutics Flagging Positive News

Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting

PRLD

GlobeNewswire

a year ago

Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting

Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting

PRLD

GlobeNewswire

a year ago

Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting

Prelude Therapeutics to Participate in Barclays Global Healthcare Conference

PRLD

GlobeNewswire

a year ago

Prelude Therapeutics to Participate in Barclays Global Healthcare Conference

PRLD

Simply Wall St.

a year ago

Here's Why We're Watching Prelude Therapeutics' (NASDAQ:PRLD) Cash Burn Situation

Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024

PRLD

GlobeNewswire

a year ago

Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024

PRLD

Business Wire

a year ago

LMP Capital and Income Fund Inc. (SCD or "the Fund"; CUSIP: 50208A102) Announces Notification of Sources of Distributions

WW International Stock Has Lost Nearly Half Its Value in Just 1 Month: Is It a Bargain or a Bust?

PRLD

Motley Fool

a year ago

WW International Stock Has Lost Nearly Half Its Value in Just 1 Month: Is It a Bargain or a Bust?

We Like These Underlying Return On Capital Trends At PlayAGS (NYSE:AGS)

PRLD

Simply Wall St.

a year ago

We Like These Underlying Return On Capital Trends At PlayAGS (NYSE:AGS)

Banc of California (BANC) Reports Q4 Loss, Tops Revenue Estimates

PRLD

Zacks

a year ago

Banc of California (BANC) Reports Q4 Loss, Tops Revenue Estimates

Northeast Bank Announces Appointment of Chief Financial Officer

PRLD

GlobeNewswire

a year ago

Northeast Bank Announces Appointment of Chief Financial Officer

LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference

PRLD

GlobeNewswire

a year ago

LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference

The past three years for NewtekOne (NASDAQ:NEWT) investors has not been profitable

PRLD

Simply Wall St.

a year ago

The past three years for NewtekOne (NASDAQ:NEWT) investors has not been profitable

Bar Harbor Bankshares Declares Quarterly Cash Dividend

PRLD

ACCESSWIRE

a year ago

Bar Harbor Bankshares Declares Quarterly Cash Dividend

Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission

PRLD

PR Newswire

a year ago

Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission

PRLD

Simply Wall St.

a year ago

Prelude Therapeutics Incorporated (NASDAQ:PRLD) is definitely on the radar of hedge funds investors who own 33% of the company

Does The Market Have A Low Tolerance For Willdan Group, Inc.'s (NASDAQ:WLDN) Mixed Fundamentals?

PRLD

Simply Wall St.

a year ago

Does The Market Have A Low Tolerance For Willdan Group, Inc.'s (NASDAQ:WLDN) Mixed Fundamentals?

Gambling.com Group to Participate at 26th Annual Needham Growth Conference on January 18

PRLD

Business Wire

a year ago

Latest Prelude Therapeutics Incorporated (PRLD) News on June 1, 2025

Share on Social Networks: